You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ANGPTL3

Showing 1 - 25 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Familial Hypobetalipoproteinemia, Familial Hypobetalipoproteinemia - Heterozygous Form Trial (Administration of deuterated

Not yet recruiting
  • Familial Hypobetalipoproteinemia
  • Familial Hypobetalipoproteinemia - Heterozygous Form
  • Administration of deuterated compounds for kinetic study
  • (no location specified)
Oct 5, 2022

Familial Partial Lipodystrophy Trial in Ann Arbor (AKCEA-ANGPTL3-LRx)

Completed
Has Results
  • Familial Partial Lipodystrophy
  • Ann Arbor, Michigan
    Clinical Site
Jan 27, 2021

Familial Chylomicronemia Syndrome, Lipoprotein Lipase Deficiency, Hyperlipoproteinemia Type 1 Trial in Montréal

Completed
Has Results
  • Familial Chylomicronemia Syndrome
  • +2 more
  • Montréal, Quebec, Canada
    Investigative Site
Dec 11, 2020

Hypertriglyceridemia, Familial Hypercholesterolemia Trial in Toronto (IONIS ANGPTL3-LRx, Placebo)

Completed
  • Hypertriglyceridemia
  • Familial Hypercholesterolemia
  • IONIS ANGPTL3-LRx
  • Placebo
  • Toronto, Ontario, Canada
    Clinical Site
Nov 17, 2020

NAFLD, Diabetes, Type 2, Hypertriglyceridemia Trial in Canada, United States (Placebo, ISIS 703802 40 mg, ISIS 703802 80 mg)

Completed
Has Results
  • NAFLD
  • +3 more
  • Placebo
  • +3 more
  • Chandler, Arizona
  • +41 more
Jan 28, 2021

Hypercholesterolemia, Familial Trial in Philadelphia, Amsterdam (Kinetics test)

Completed
  • Hypercholesterolemia, Familial
  • Kinetics test
  • Philadelphia, Pennsylvania
  • +1 more
May 14, 2021

Severe Hypertriglyceridemia (sHTG) Trial in Worldwide (evinacumab, Placebo)

Completed
  • Severe Hypertriglyceridemia (sHTG)
  • Boca Raton, Florida
  • +16 more
Dec 16, 2020

Homozygous Familial Hypercholesterolemia Trial (Evinacumab)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • (no location specified)
Nov 3, 2022

Genetic Pathways Leading to Fatty Liver and Atherogenic

Enrolling by invitation
  • Non-alcoholic Fatty Liver
  • +2 more
  • Lipoprotein kinetics
  • Helsinki, Finland
  • +1 more
Apr 11, 2022

Hyperlipidemia Trial in Beijing (JS401, Placebo)

Recruiting
  • Hyperlipidemia
  • Beijing, Beijing, China
    Peking University Third Hospital
Sep 15, 2023

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Cholesterol metabolism disruption
  • Quebec city, Quebec, Canada
    CHU de Québec-Université Laval
Oct 17, 2022

Healthy Trial in Athens (Pecan Breakfast Shake, Cream Breakfast Shake)

Recruiting
  • Healthy
  • Pecan Breakfast Shake
  • Cream Breakfast Shake
  • Athens, Georgia
    University of Georgia- Department of Foods and Nutrition
May 17, 2022

Homozygous Familial Hypercholesterolemia Trial in Québec (AKCEA-ANGPTL3-LRX)

Withdrawn
  • Homozygous Familial Hypercholesterolemia
  • Québec, Quebec, Canada
    Clinical Site
Nov 29, 2018

Homozygous Familial Hypercholesterolemia Trial in Australia, Canada, United States (ARO-ANG 3 Injection)

Recruiting
  • Homozygous Familial Hypercholesterolemia
  • ARO-ANG 3 Injection
  • Mount Sinai, New York
  • +7 more
Sep 26, 2022

Dyslipidemias, Familial Hypercholesterolemia, Hypertriglyceridemia Trial (VSA003, 0.9% NaCl)

Not yet recruiting
  • Dyslipidemias
  • +2 more
  • (no location specified)
May 9, 2023

Knee Osteoarthritis Trial in Worldwide (canakinumab, LNA043, Placebo to canakinumab)

Recruiting
  • Knee Osteoarthritis
  • canakinumab
  • +2 more
  • Clearwater, Florida
  • +19 more
Dec 14, 2022

Mixed Dyslipidemia Trial in Worldwide (ARO-ANG3, Placebo)

Active, not recruiting
  • Mixed Dyslipidemia
  • Huntington Park, California
  • +23 more
Jun 27, 2022

Dyslipidemias, Overweight and Obesity, Nutrition, Healthy Trial in Athens (Pecan LOW, Pecan MID, Pecan HIGH)

Not yet recruiting
  • Dyslipidemias
  • +2 more
  • Pecan LOW
  • +3 more
  • Athens, Georgia
    University of Georgia
Jul 9, 2023

Integrative Multi-Omics Testing for Immunotherapy Response in

Recruiting
  • Lung Cancer
    • Guangzhou, Guangdong, China
      Nanfang hospital
    Jun 29, 2023

    Dyslipidemias, Hyperlipidemias, Hyperlipoproteinemias Trial in Canada, Poland, United States (Vupanorsen, Placebo)

    Completed
    • Dyslipidemias
    • +2 more
    • Gilbert, Arizona
    • +112 more
    Jan 6, 2022

    Dyslipidemias, Overweight and Obesity, Nutrition, Healthy Trial in Athens (CSO LOW, CSO MID, CSO HIGH)

    Recruiting
    • Dyslipidemias
    • +2 more
    • CSO LOW
    • +3 more
    • Athens, Georgia
      University of Georgia
    Jan 13, 2023

    Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases Trial in Worldwide (LY3561774, Placebo)

    Recruiting
    • Dyslipidemias
    • +3 more
    • Waterbury, Connecticut
    • +40 more
    Aug 17, 2022

    Knee Cartilage Lesion Trial in Wien (LNA043, to LNA043)

    Terminated
    Has Results
    • Knee Cartilage Lesion
    • LNA043
    • placebo to LNA043
    • Wien, Austria
    • +1 more
    Oct 6, 2021

    Hypercholesterolemia Trial in Changchun (DC371739 Tablets, Placebo)

    Completed
    • Hypercholesterolemia
    • DC371739 Tablets
    • Placebo
    • Changchun, Ji Lin, China
      The First Hospital of Jilin University
    Mar 15, 2022

    Healthy Trial in Athens (Control, Pecan)

    Completed
    • Healthy
    • Control
    • Pecan
    • Athens, Georgia
      University of Georgia - Department of Foods and Nutrition & Depa
    Apr 13, 2021